Schizophrenia Clinical Trials

Showing 1021-1040 of 1,172 trials

Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics

NCT00628420

To determine the safety and tolerability of ACP-104 after oral administration of single doses in comparison with placebo to schizophrenia or other psychotic disorders.

Schizophrenia

University of Texas Southwestern Medical Center45 participantsStarted Jan 2005

Dallas, Texas, United States • Dallas, Texas, United States

COMPLETEDNA

The Compliance Project Concerning People With Schizophrenia

NCT00497848

The purpose of this study is to determine whether individual and/ or system orientated interventions can help the problem of people with schizophrenia dropping out of their drug treatment

Schizophrenia

Ministry of the Interior and Health, Denmark70 participantsStarted May 2007

Odense, Denmark

COMPLETED

Evaluation of Dorsal Visual Stream in Patients With Schizophrenia

NCT01378403

Schizophrenia patients in comparing to normal controls show decreased ability to identify objects with decreased level of fragmentation, a task that is associated with magnocellular pathway function.

Schizophrenia

Sheba Medical Center22 participantsStarted Sep 2007

Ramat Gan, Israel

Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics

The Compliance Project Concerning People With Schizophrenia

Evaluation of Dorsal Visual Stream in Patients With Schizophrenia

Related Searches

Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study

A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.

A Bioequivalence Study of 15 mg ER OROS Paliperidone

A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia.

Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia

A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone

Investigate Risperidone for the Treatment of Schizophrenia in Adolescents

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia

A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone

Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia

Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients

ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry

A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine